Total Payments
$10,823
2024 Payments
$751.52
Companies
30
Transactions
282
Medicare Patients
10,206
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$8,289 (76.6%)
Travel$2,434 (22.5%)
Education$99.99 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,289 | 272 | 76.6% |
| Travel and Lodging | $2,434 | 9 | 22.5% |
| Education | $99.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $3,344 | 53 | $0 (2023) |
| Abbott Laboratories | $3,001 | 95 | $0 (2024) |
| Relievant Medsystems, Inc. | $980.66 | 8 | $0 (2023) |
| DePuy Synthes Sales Inc. | $430.33 | 19 | $0 (2019) |
| Medtronic USA, Inc. | $354.74 | 7 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $350.40 | 25 | $0 (2023) |
| Medtronic, Inc. | $329.16 | 4 | $0 (2024) |
| MML US, Inc. | $216.62 | 2 | $0 (2024) |
| Nalu Medical, Inc. | $214.62 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $212.36 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.52 | 10 | MML US, Inc. ($216.62) |
| 2023 | $1,907 | 24 | Relievant Medsystems, Inc. ($921.72) |
| 2022 | $574.82 | 19 | Abbott Laboratories ($211.83) |
| 2021 | $695.58 | 37 | Abbott Laboratories ($234.97) |
| 2020 | $1,237 | 42 | Abbott Laboratories ($976.80) |
| 2019 | $3,695 | 62 | Nevro Corp. ($2,523) |
| 2018 | $840.00 | 32 | Abbott Laboratories ($387.66) |
| 2017 | $1,122 | 56 | Nevro Corp. ($318.14) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Pain Management | ||||||
| 11/06/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $145.95 | General |
| Category: Pain management | ||||||
| 10/23/2024 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $106.15 | General |
| Category: Image Guided Surgery Products | ||||||
| 09/16/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $196.82 | General |
| Category: Pain Management | ||||||
| 08/19/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: Pain Management | ||||||
| 05/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Neuromodulation | ||||||
| 04/27/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/27/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/11/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $128.04 | General |
| Category: Not Applicable | ||||||
| 12/21/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $183.35 | General |
| Category: Neuromodulation | ||||||
| 12/21/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $123.22 | General |
| Category: Neuromodulation | ||||||
| 12/21/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Neuromodulation | ||||||
| 11/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Neuromodulation | ||||||
| 11/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $144.43 | General |
| Category: Neuromodulation | ||||||
| 11/14/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Neuromodulation | ||||||
| 11/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Neuromodulation | ||||||
| 11/01/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $137.19 | General |
| Category: Pain Management | ||||||
| 10/18/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/06/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $292.71 | General |
| Category: Pain | ||||||
| 10/06/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: Pain | ||||||
| 08/29/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: Pain | ||||||
| 08/29/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $23.25 | General |
| Category: Pain | ||||||
| 08/28/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $57.38 | General |
| Category: Pain | ||||||
| 08/26/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| Category: Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,542 | 9,233 | $1.4M | $424,411 |
| 2022 | 24 | 2,677 | 9,744 | $1.4M | $432,449 |
| 2021 | 22 | 2,484 | 9,691 | $1.3M | $429,910 |
| 2020 | 28 | 2,503 | 9,816 | $1.2M | $379,070 |
Total Patients
10,206
Total Services
38,484
Medicare Billing
$1.7M
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 333 | 493 | $379,332 | $115,975 | 30.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 92 | 101 | $140,880 | $45,558 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 352 | 681 | $152,939 | $44,573 | 29.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 107 | 178 | $105,792 | $31,803 | 30.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 117 | 163 | $84,261 | $25,510 | 30.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 82 | 90 | $53,152 | $22,930 | 43.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 37 | 49 | $54,791 | $17,723 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 173 | $55,184 | $15,934 | 28.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 102 | 167 | $51,098 | $15,846 | 31.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 45 | 78 | $47,835 | $14,772 | 30.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 52 | 61 | $40,695 | $12,097 | 29.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 97 | 125 | $34,824 | $11,108 | 31.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 42 | 42 | $20,868 | $8,180 | 39.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 28 | 36 | $18,491 | $7,911 | 42.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 45 | 73 | $22,660 | $7,113 | 31.4% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Office | 2023 | 14 | 14 | $22,359 | $6,705 | 30.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 52 | 62 | $17,656 | $5,024 | 28.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 457 | 4,726 | $15,265 | $4,010 | 26.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 63 | 73 | $12,346 | $3,827 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $13,250 | $3,656 | 27.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 41 | 41 | $6,369 | $2,497 | 39.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 96 | 114 | $3,061 | $1,061 | 34.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 14 | 14 | $1,358 | $442.26 | 32.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 92 | 1,631 | $668.71 | $156.57 | 23.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 369 | 557 | $420,523 | $129,063 | 30.7% |
About Dr. Eric Feldman, MD
Dr. Eric Feldman, MD is a Interventional Pain Medicine healthcare provider based in Sun City West, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477509693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Feldman, MD has received a total of $10,823 in payments from pharmaceutical and medical device companies, with $751.52 received in 2024. These payments were reported across 282 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($8,289).
As a Medicare-enrolled provider, Feldman has provided services to 10,206 Medicare beneficiaries, totaling 38,484 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation, Rehabilitation Practitioner
- Location Sun City West, AZ
- Active Since 05/26/2006
- Last Updated 03/25/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1477509693
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $2,950
- Proclaim Family of SCS IPGs (Device) $1,231
- Intracept (Device) $980.66
- PROCLAIM (Device) $749.04
- Omnia (Device) $376.74
- VERTECEM (Device) $335.69
- Octrode SCS Leads (Device) $313.18
- XTAMPZA (Drug) $277.89
- ReActiv8 (Device) $216.62
- Nalu Neurostimulation System (Device) $214.62
- INTELLIS (Device) $192.94
- Proclaim IPG (Device) $192.64
- SCS IPGs (Device) $178.64
- Morphabond ER (Drug) $165.64
- ADAPTIVESTIM (Device) $161.80
- SPRINT PNS System (Device) $145.95
- WaveWriter Alpha Prime 16 (Device) $144.18
- DRG IPGs (Device) $136.41
- Prospera (Device) $128.04
- EXPAREL (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.